Search - tctmd.com

Displaying 841 - 860 of 913

Sort: Relevancy | Date

News Daily News

PRODIGY Published: No Advantage to Long-term Clopidogrel

April 03, 2012

News Daily News

PCI for Left Main Disease Uncommon in US Clinical Practice

Jason Kahn

March 23, 2012

News Daily News

Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI

Caitlin E. Cox

March 20, 2012

News Daily News

Societies Recommend TAVR Program Requirements

L.A. McKeown

March 06, 2012

News Daily News

Right Coronary CTO Forecasts Mortality After Left Main PCI

Leah Lawrence

March 06, 2012

News Daily News

Mode of Revascularization Influenced by Angiographer, Hospital ‘Culture’

March 06, 2012

News Daily News

PCI-Related Stroke Rare, Tied to Modifiable Procedural Factors

Yael L. Maxwell

March 06, 2012

News Daily News

Registry Characterizes Prevalence, Management of CTOs Found on Diagnostic Cath

March 05, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

News Daily News

Live Case Procedures Just as Safe as in Daily Practice

Caitlin E. Cox

February 21, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Yael L. Maxwell

February 20, 2012

News Daily News

Paper Sparks Renewed Discussion on Appropriate Use of PCI

Yael L. Maxwell

February 08, 2012

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Conference News

PROTECT II: Positive Outcomes Observed with Impella Device

November 08, 2011

News Industry News

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

November 08, 2011

Advertisement

PRODIGY Published: No Advantage to Long-term Clopidogrel

PCI for Left Main Disease Uncommon in US Clinical Practice

Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI

Societies Recommend TAVR Program Requirements

Right Coronary CTO Forecasts Mortality After Left Main PCI

Mode of Revascularization Influenced by Angiographer, Hospital ‘Culture’

PCI-Related Stroke Rare, Tied to Modifiable Procedural Factors

Registry Characterizes Prevalence, Management of CTOs Found on Diagnostic Cath

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Live Case Procedures Just as Safe as in Daily Practice

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Paper Sparks Renewed Discussion on Appropriate Use of PCI

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

PRISM Individualized Informed Consent Improves PCI Choice, Experience

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

PROTECT II: Positive Outcomes Observed with Impella Device

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content